ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹205 Cr | ₹189 Cr | ₹181 Cr | ₹135 Cr | ₹149 Cr |
What is the latest Total Current Liabilities ratio of ALBERT DAVID ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹205 Cr |
Mar2023 | ₹189 Cr |
Mar2022 | ₹181 Cr |
Mar2021 | ₹135 Cr |
Mar2020 | ₹149 Cr |
How is Total Current Liabilities of ALBERT DAVID Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹205 Cr | 8.82 | |
Mar2023 | ₹189 Cr | 4.19 | |
Mar2022 | ₹181 Cr | 33.92 | |
Mar2021 | ₹135 Cr | -8.94 | |
Mar2020 | ₹149 Cr | - |
Compare Total Current Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹472.1 Cr | 3.6% | 2.7% | -25% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,519.0 Cr | 1.6% | -2.9% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,903.0 Cr | 1.5% | 10.4% | 51.9% | Stock Analytics | |
CIPLA | ₹121,669.0 Cr | 2.3% | 1.9% | 2.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,097.0 Cr | 5.7% | 14.1% | 15.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,605.0 Cr | 1.4% | 1.3% | 17% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 3.6% |
2.7% |
-25% |
SENSEX | 1.3% |
2.6% |
7.8% |
You may also like the below Video Courses